tiprankstipranks
Advertisement

FNY - ETF AI Analysis

Compare

Top Page

FNY

First Trust Mid Cap Growth AlphaDEX Fund (FNY)

Rating:67Neutral
Price Target:
FNY, the First Trust Mid Cap Growth AlphaDEX Fund, has an overall rating that suggests it is a solid but not flawless mid-cap growth option, supported by several strong individual stocks. Standout holdings like Krystal Biotech and Enova International help lift the fund’s quality with strong financial performance, growth, and positive corporate actions, while names such as Etsy and Cytokinetics introduce more risk due to financial instability, valuation concerns, and mixed technical signals. The main risk for investors is that many top holdings share themes of high leverage, rich valuations, and occasional overbought technical conditions, which can make the fund more sensitive to market pullbacks.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and over the past month, indicating positive recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors such as industrials, health care, technology, and consumer-related areas, which helps reduce the impact of weakness in any single industry.
Multiple Strong Top Holdings
Several of the largest positions have delivered strong year-to-date results, supporting the fund’s overall performance.
Negative Factors
High Expense Ratio
The fund’s management fee is relatively high for an ETF, which can eat into long-term returns compared with lower-cost options.
Heavy U.S. Concentration
Almost all of the ETF’s assets are invested in U.S. companies, offering little geographic diversification if the U.S. market struggles.
Mid-Cap Growth Volatility
Because the fund focuses on mid-sized growth companies, its share price may be more sensitive to market swings than funds holding larger, more established firms.

FNY vs. SPDR S&P 500 ETF (SPY)

FNY Summary

The First Trust Mid Cap Growth AlphaDEX Fund (FNY) is an ETF that follows the NASDAQ AlphaDEX Mid Cap Growth Index, focusing on medium‑sized U.S. companies with strong growth potential. It spreads your money across many sectors, with a tilt toward industrials, health care, and technology. Some of its holdings include companies like ViaSat and Sanmina-Sci. An investor might choose this ETF to seek long-term growth and diversify beyond large, well-known blue-chip stocks. However, because it targets growth-focused mid-sized companies, its price can move up and down more sharply than the overall market.
How much will it cost me?The expense ratio for the First Trust Mid Cap Growth AlphaDEX Fund (FNY) is 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because the fund is actively managed, using a specialized methodology to select and weight stocks for potential growth. Active management typically involves higher costs compared to passively managed funds that track an index.
What would affect this ETF?The First Trust Mid Cap Growth AlphaDEX Fund (FNY) could benefit from positive trends in the U.S. economy, such as technological advancements and increased demand for industrial and healthcare innovations, given its strong exposure to these sectors. However, it may face challenges from rising interest rates, which can negatively impact growth-focused companies, and potential economic slowdowns that could reduce consumer spending and affect cyclical sectors. Regulatory changes or geopolitical tensions could also influence the performance of its top holdings in industries like energy and materials.

FNY Top 10 Holdings

FNY’s story is all about U.S. mid-cap growth names, with a clear tilt toward industrials and tech that are doing most of the heavy lifting. Rising stars like Sterling Infrastructure, Vicor, and TTM Technologies are powering the fund, helped by steady contributors such as Sanmina and Powell Industries. DigitalOcean is also climbing, though its stretched finances add a bit of wobble to the ladder. On the weaker side, TeraWulf is dragging its feet, reminding investors that this otherwise diversified, U.S.-focused fund still carries some high-risk passengers.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Etsy0.88%$5.12M$7.98B39.10%
57
Neutral
PACS Group Inc0.83%$4.81M$7.30B284.94%
66
Neutral
Victoria's Secret0.83%$4.81M$6.47B338.80%
71
Outperform
Amneal Pharmaceuticals0.80%$4.64M$5.70B121.24%
58
Neutral
BrightSpring Health Services, Inc.0.80%$4.64M$13.87B257.69%
67
Neutral
Madison Square Garden Sports0.78%$4.55M$9.56B94.49%
45
Neutral
Guardant Health0.78%$4.53M$20.67B224.43%
61
Neutral
TG Therapeutics0.78%$4.51M$8.40B44.20%
65
Neutral
Tutor Perini0.77%$4.45M$4.14B64.47%
65
Neutral
frontdoor0.76%$4.43M$5.32B30.59%
72
Outperform

FNY Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
104.78
Negative
100DMA
100.06
Positive
200DMA
96.80
Positive
Market Momentum
MACD
-0.46
Positive
RSI
41.74
Neutral
STOCH
14.26
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FNY, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 106.49, equal to the 50-day MA of 104.78, and equal to the 200-day MA of 96.80, indicating a neutral trend. The MACD of -0.46 indicates Positive momentum. The RSI at 41.74 is Neutral, neither overbought nor oversold. The STOCH value of 14.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FNY.

FNY Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$583.68M0.73%
67
Neutral
$353.20M0.31%
69
Neutral
$340.98M0.35%
72
Outperform
$166.67M0.80%
74
Outperform
$143.09M0.60%
59
Neutral
$112.97M0.85%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FNY
First Trust Mid Cap Growth AlphaDEX Fund
104.56
19.84
23.42%
NUMG
Nuveen ESG Mid-Cap Growth ETF
RFG
Invesco S&P Midcap 400 Pure Growth ETF
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
FRTY
Alger Mid Cap 40 ETF
TMFM
Motley Fool Mid-Cap Growth ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement